SynthesisInfectious disorders drug targets2024

Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence.

SeyedAhmad SeyedAlinaghi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.